Ownership

Daniel L. Alkon

Insider Reports History

Entity: Individual
Location: C/O Neurotrope, Ine., 205 East 42 Nd Street 20 Th Floor, New York, NY
Signature: /s/ Robert Weinstein, Attorney-in-fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel L. Alkon:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Synaptogenix, Inc.	President and CSO, Director	Common Stock, par value $0.0001 per share	35.5K	$41.7K	$1.17	Dec 16, 2022	Direct

Showing 1 to 1 of 1 entries

Insider Reports Filed by Daniel L. Alkon

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
SNPX	Synaptogenix, Inc.	Dec 16, 2022	1	-$23.1K	4	Dec 20, 2022	President and CSO, Director
SNPX	Synaptogenix, Inc.	Nov 15, 2022	1	$0	4/A	Dec 1, 2022	President and Chief Scientific Officer, Director
SNPX	Synaptogenix, Inc.	Jul 13, 2021	1	$0	4/A	Dec 1, 2022	President and CSO, Director
SNPX	Synaptogenix, Inc.	Jun 14, 2021	1	$82.6K	4	Jun 16, 2021	Chief Scientific Officer, Director
SNPX	Synaptogenix, Inc.	Jun 4, 2021	0	$0	3	Jun 14, 2021	Chief Scientific Officer, Director